G Cooke Bugs, Babies & Vitamin K
-
Upload
gordon-cooke -
Category
Education
-
view
145 -
download
3
description
Transcript of G Cooke Bugs, Babies & Vitamin K
BugsBugs, ,
BabiesBabies & Vitamin K& Vitamin K
Gordon Cooke, Dept of Applied Gordon Cooke, Dept of Applied Science, Institute of Science, Institute of Technology Tallaght.Technology Tallaght.
ObjectivesObjectives
• To examine, by enumeration, the development of the major groups of bacteria within the faecal flora of new born infants over three different time points.
• To determine any statistically significant differences between the faecal flora of breast and formula fed
infants at each of the different time points.
• To identify, to species level, selected representative isolates from the enumerated faecal flora and evaluate the production of vitamin K by these
selected isolates.
• To examine the toxicity and absorption of various forms of Vitamin K across human intestinal cells.
Introduction-Vitamin KIntroduction-Vitamin K
• Vitamin K– Phylloquinone (MW: 450)– Menaquinone (MW: 444)– Menadione (MW: 172)
• Roles– Blood Clotting Process– Bone Health– Possible Neurological Growth Factor
Introduction-Vitamin KIntroduction-Vitamin K
• Haemorrhagic Disease of the Newborn (HDN)• Deficiency in Vitamin K
– Low levels present in Breast Milk– Supplemented in Formula Milk
• 3 Types– Early: 0-24hrs– Classical: 2-7 days– Late: up to 1 year after birth
• Occurrences• Vitamin K Prophylaxis
– No Consensus
Methods-Gut FloraMethods-Gut Flora
• Full Term Healthy Neonates• 3 Sampling Periods
– Birth to 1 day old Neonates– 2-5 day old Neonates– 6 week old Neonates
• Bacteria Enumerated and Identified– Selective Media– Gram Stains– API Tests
Bacterial Groups Bacterial Groups EnumeratedEnumerated
Media: Bacteria IsolatedRogosa –O2: Lactobacilli sp.
RCA –O2: Clostridia sp.
RCA & Analine Blue –O2: Bifidobacteria sp.
BBAA –O2: Bacteroides sp.
EMB +O2: E.coli and
Enterobacteriaceae sp.Baird Parker +O2: Staphylococci sp.
Slanetz and Bartley +O2: Enterococci sp.
Bifidobacteria Bifidobacteria spsp. . 100x100x
Lactobacilli Lactobacilli spsp. . 100x100x
Reinforced Clostridial agar Reinforced Clostridial agar with Analine Bluewith Analine Blue
Rogosa AgarRogosa Agar
0%50%56%0%43%26%25%46%% Dominance
7%30%33%7%26%85%44%48%% of Samples testing positive
2727272727272727Total number of samples tested
Bacteroides sp.
Enterobacteriaceae sp.
E. coliClostridia
sp.Lactobacilli
sp.Staphylococci
sp.Enterococci
sp.Bifidobacteria
sp.Bacteria
Formula
33%17%33%0%0%15%38%60%% Dominance
21%43%43%7%29%93%57%71%% of Samples testing positive
1414141414141414Total number of samples tested
Bacteroides sp.
Enterobacteriaceae sp.
E. coliClostridia
sp.Lactobacilli
sp.Staphylococci
sp.Enterococci
sp.Bifidobacteria
sp. Bacteria
Breast
Table 1. Percentage of Positive Samples and Dominance in Breast Table 1. Percentage of Positive Samples and Dominance in Breast and Formula Fed Neonates Aged 2-5 Days Old and Formula Fed Neonates Aged 2-5 Days Old
10%36%40%0%17%0%17%67%% Dominance
59%65%59%6%71%88%94%35%% of Samples
testing positive
1717171717171717Total number of
samples tested
Bacteroides sp.
Enterobacteriaceae sp.
E. coliClostridia
sp.Lactobacilli sp.
Staphylococci sp.
Enterococci sp.Bifidobacteria
sp.Bacteria
Formula
33%13%0%0%45%6%0%80%% Dominance
75%75%38%6%69%100%75%31%% of Samples
testing positive
1616161616161616Total number of
samples Tested
Bacteroides sp.
Enterobacteriaceae sp.E. coli
Clostridia sp.
Lactobacilli sp.Staphylococci
sp.Enterococci sp.
Bifidobacteria sp.Bacteria
Breast
Table 2.Percentage of Positive Samples and Dominance in 6 Week Old Breast and Formula Fed NeonatesTable 2.Percentage of Positive Samples and Dominance in 6 Week Old Breast and Formula Fed Neonates
Statistically significant results in the gut flora of Statistically significant results in the gut flora of neonates aged 2-5 Days Oldneonates aged 2-5 Days Old
In the gut flora of breast fed neonates aged 2-5 days old, on
average, Bifidobacteria sp. accounted for 36.35% of all
bacteria enumerated whereas in formula fed neonates they accounted for 12.81% of all
bacteria enumerated. (p=0.03).
Statistically significant results in the gut flora of Statistically significant results in the gut flora of neonates aged 6 weeks oldneonates aged 6 weeks old
In the gut flora of breast fed neonates aged 6 weeks old, on
average, Lactobacilli sp. accounted for 25.04% of all
bacteria enumerated whereas in formula fed neonates they
accounted for 2.85% of all bacteria enumerated. (p=0.03)
Statistically significant results in the gut flora of Statistically significant results in the gut flora of neonates aged 6 weeks oldneonates aged 6 weeks old
In the gut flora of breast fed neonates aged 6 weeks old, on
average, Enterococci sp. accounted for 5.44% of all
bacteria enumerated whereas in formula fed neonates they accounted for 16.60% of all
bacteria enumerated. (p=0.04)
Methods-Vitamin K2Methods-Vitamin K2
• Total lipid content isolated from selected identified species
• Suspect menaquinones purified and visualised on TLC and detected on
HPLC
• Confirmatory identification of menaquinones carried out using LC-MS
Results of Thin Layer Chromatography Results of Thin Layer Chromatography Purification of Bacterial Lipid ExtractPurification of Bacterial Lipid Extract
A TLC plate with lipid extract of E.coli
and B.bifidum showing that E.coli
produces Menaquinone
whereas B.bifidum does not.
Bacterial Menaquinones Menaquinone
Standard
Results of LC-MS Analysis of Purified Results of LC-MS Analysis of Purified Suspect Menaquinone Bands from TLCSuspect Menaquinone Bands from TLC
Peak A 647.5
Peak A
LC-MS scan of Bacteroides sp. Peak A had a mass of 647.5 and MK7 has a mass of 648.
Vitamin K ProductionVitamin K ProductionMenaquinone Producers Non Menaquinone ProducersStaphylococcus warneri Lactobacilli sp.Staphylococcus warneri Clostridia sp.
Staphylococcus haemolyticus Propionibacterium acnesEnterobacter agglomerans Bifidobacterium bifidum
Serratia marcescens Lactobacilli sp.Staphylococcus capitis
Escherichia coliPrevotella buccaeBacteroides sp.Bacteroides sp.
Enterococcus faecalisEnterococcus faecium
Staphylococcus epidermidisBacteroides ovatus
Toxicity StudiesToxicity Studies
• WST-1 (Tetrazolium Salt)– One Step Reaction– Concentration Range 0-1000ug/ml– 24hr incubation– n=3
• Cells– CACO-2 Non Mucosal Human Intestinal Cells– HT-29 Mucosal Human Intestinal Cells
% Survival of HT-29 Cells dosed with various concentrations of Vitamin K2
0
20
40
60
80
100
120
140
Concentration of Vitamin K2 in ug/ml
% S
urv
ival
% Survival of Caco-2 Cells dosed with various concentrations of Vitamin K3
0
20
40
60
80
100
120
Concentration of Vitamin K3 in ug/ml
% S
urvi
val
% Survival of Caco-2 Cells dosed with various concentrations of Vitamin K2
0
20
40
60
80
100
120
140
160
Concentration of Vitamin K2 in ug/ml
% S
urv
ival
% Survival of Caco-2 Cells dosed with various concentrations of Vitamin K1
0
20
40
60
80
100
120
140
160
Concentration of vitamin K1
% S
urv
ival
IC50 Values For Menadione
μg/ml μM
HT-29 45 261
CACO-2 12 70
% Survival of HT-29 Cells dosed with various concentrations of Vitamin K1
0
20
40
60
80
100
120
140
Concentration of vitamin K1
% S
urv
ival
% Survival of HT-29 Cells dosed with various concentrations of Vitamin K3
0
20
40
60
80
100
120
Concentration of Vitamin K3 in ug/ml
% S
urvi
val
Transport StudiesTransport Studies
• Transwells– CACO-2 cells– Apical to Basolateral movement– Basolateral to Apical Movement
• Monitored TEER values • HPLC-UV analysis
Transport StudiesTransport Studies• Phylloquinone and Menaquinone
– No Absorption across CACO-2 intestinal cells– TEER values remained high
• Menadione– Papp= 1.27x10-7 cm/s Apical-Basolateral (+/-0.68)
– Papp= 2.05x10-7 cm/s Basolateral-Apical (+/-1.4)
– TEER values dropped 50% after 2 hours
• Preliminary work with Cytochalasin D– No absorption of Phylloquinone and Menaquinone– Adhere to the cell
TEER values for CACO-2 with 100ug/ml of Phylloquinone
0102030405060708090
100110120130
0 1 2 3 4 5 6 7
Time after Drug addition (hrs)
TE
ER
val
ue
as a
% o
f co
ntr
olw
ith
n
o d
rug
TEER values for CACO-2 with 100ug/ml of Menaquinone
0102030405060708090
100110120
0 1 2 3 4 5 6 7
Time after Drug addition (hrs)
TE
ER
val
ue
as a
% o
f co
ntr
olw
ith
n
o d
rug
TEER values for CACO-2 with 100ug/ml of Menadione
0
10
20
30
40
50
60
70
80
90
100
0 1 2 3 4 5 6 7
Time after Drug Addition (hrs)
TE
ER
val
ue
as a
% o
f co
ntr
olw
ith n
o
dru
g
ConclusionsConclusions
• Breast-fed Neonates– Higher levels of Bifidobacteria and Lactobacilli
• Formula-fed Neonates– Higher levels of E.coli and Enterococci
• Menaquinone production in gut flora– Confirmed– New previously unknown producers of menaquinones
identified• Phylloquinone and Menaquinone
– Non-toxic– Does not absorb across intestinal cells in-vitro over a 6
hour period• Menadione
– Toxic– Absorbs across intestinal cells in-vitro over a 6 hour
period• Hospital recommendations
AcknowledgementsAcknowledgements
• Dr. Mary Costello & John Behan• Sr. Nicola Clarke CMS (Clinical Midwife Specialist
N.M.H)• Dr. Winifred Gorman (Paediatric Consultant N.M.H)• Brian Carr, Dr Mary Deasy, Dr Siobhán McClean, Dr
Brian Murray, James Reilly and Dr Maureen Walsh • Dr Brett Paul, Leon Bannon and DCU
• PDRSP for funding, IT Tallaght Seed fund and Ph.D. continuance fund.
• The mothers and their newborns of the National Maternity Hospital Holles Street
CACO-2 cells in a MTP with WST-1 only
CACO-2 cells in a MTP with WST-1 and 25μg/ml
of Menadione